The stratified analysis on GH treatment shows that osteoporosis/osteopenia, hypercholesterolemia, DM2, obesity and hypertension rates are higher in adults who never received GH treatment (Table 3). Here, GH1 is linked to obesity due to melanocortin 4 receptor deficiency.